Neuphoria Therapeutics Inc.

NEUP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 8 employees
87
SEC Filings
$5.36
Close 2026-05-28
8
Employees

Business Summary

. Overview We are a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. Neuphoria is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the 7 nicotinic acetylcholine ("ACh") receptor ("a7 receptor") for the acute, as needed treatment of social anxiety disorder (SAD) and for chronic treatment of post-traumatic stress disorder (PTSD). The...

Latest Stock Quote

NEUP 2026-05-28 $5.36 O:$5.43 H:$5.48 L:$5.2206 Vol:0.0M VWAP:$5.3341
origin leaf: ce83dfea5e76cd151af524e2f9b89b9d5a01c28e53126d5ba535be95598c14cf

Next Earnings

Q2 FY2026 — expected 2026-09-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-09-292025-06-300001193125-25-223338EDGAR103K words
2024-09-302024-06-300001213900-24-082909EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-172025-12-310001193125-26-054509EDGAR25K words
2025-11-142025-09-300001193125-25-281579EDGAR—
2025-05-202025-03-310000950170-25-075175EDGAR—
2025-02-142024-12-310000950170-25-020473EDGAR—
2024-11-142024-09-300000950170-24-127032EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-01-080001213900-26-002245EDGAR7K words
2025-12-180001213900-25-123289EDGAR—
2025-12-170001213900-25-122777EDGAR—
2025-10-270001213900-25-102607EDGAR—
2025-10-200001213900-25-100371EDGAR—
2025-09-160001213900-25-087950EDGAR—
2025-07-180001213900-25-065723EDGAR—
2025-05-200001213900-25-045970EDGAR—
2025-01-140001213900-25-003492EDGAR—
2024-12-230001213900-24-112016EDGAR—

87 total filings indexed. 70 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001191070
TickerNEUP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedC3
Websitehttps://www.neuphoriatx.com
Listed2021-12-16

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 89761c4cfb63490440f75b6887d3db4203f45e0010c905e0f2f80e2367ec0961
parent: d70eeada059616138e17ee7c66e2e4030ec7a0e8c8ca4cea2fc9dbf889505d3c
content hash: 041963cacb283c3da83c421c902fd3b8ea431355cdfaf60df3f9249e06bce2a9
signed: 2026-06-02T19:02:01.577Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf